Maria João Gomes

Bial (Portugal) — Portugal

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

13h-index855citations29works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Drug Delivery Systems(10), Nanoparticle-Based Drug Delivery(8), RNA Interference and Gene Delivery(6), MicroRNA in disease regulation(3), Drug Transport and Resistance Mechanisms(3)

Publications29 total

Dataset from In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. Expert Opinion on Drug Delivery Volume 16, 2019 - Issue 12 (v.0)
2024Open Access
Cell-Based Intestinal In Vitro Models for Drug Absorption Screening
2024
Cell-Based Intestinal In Vitro Models for Drug Absorption Screening
2022· 3 cited
Osler-Weber-Rendu Syndrome with Severe Hepatic Manifestations: A Rare Clinical Case
European Journal of Case Reports in Internal Medicine·2020· 5 citedOpen Access
Body-Packing: A Rare Diagnosis to Keep in Mind
European Journal of Case Reports in Internal Medicine·2020· 5 citedOpen Access
<i>In vivo</i> biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles
Expert Opinion on Drug Delivery·2019· 45 cited
A Rare Presentation of Ogilvie's Syndrome
European Journal of Case Reports in Internal Medicine·2019· 8 citedOpen Access
<i>In vivo</i> biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles
Figshare·2019Open Access
Development of a PEGylated-Based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood–Brain Barrier
Bioconjugate Chemistry·2018· 39 cited
Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
European Journal of Pharmaceutics and Biopharmaceutics·2018· 83 cited
Delivery of siRNA Silencing P-gp in Peptide-Functionalized Nanoparticles Causes Efflux Modulation at the Blood–Brain Barrier
Nanomedicine·2017· 51 cited
Modulation of drug efflux at the blood-brain barrier through targeted siRNA delivery via nanoparticles
Open Repository of the University of Porto (University of Porto)·2017Open Access
Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier – from Targeting to Safe Administration
Journal of Neuroimmune Pharmacology·2016· 54 cited
Drug Delivery: Thiolation and Cell‐Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin (Adv. Funct. Mater. 20/2016)
Advanced Functional Materials·2016· 6 citedOpen Access
Thiolation and Cell‐Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin
Advanced Functional Materials·2016· 109 cited
Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
Journal of Controlled Release·2016· 62 cited
A new approach for a blood-brain barrier model based on phospholipid vesicles: Membrane development and siRNA-loaded nanoparticles permeability
Journal of Membrane Science·2016· 15 cited
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
Nanoscale·2016· 73 citedOpen Access
List of contributors
Elsevier eBooks·2015
Cell-based in vitro models for studying blood–brain barrier (BBB) permeability
Elsevier eBooks·2015· 23 cited
page 1 of 2Next →

Frequent Co-authors

Bruno Sarmento(20), Susana Martins(8), Francisca Araújo(6), Neha Shrestha(5), Jouni Hirvonen(5), Hélder A. Santos(5), Cláudia Martins(5), Bárbara B. Mendes(4), Mohammad‐Ali Shahbazi(3), Ermei Mäkilä(3), Bárbara Herranz‐Blanco(3), Jarno Salonen(3), Carlos Fernandes(3), Fernanda Borges(3), María Dolores Cayero Otero(3), Mercedes Fernández Arévalo(3), Teófilo Vasconcelos(3), Domingos Ferreira(2), Rici Lindgren(2), Sari Granroth(2)